BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for July 29, 2022

July 29, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acasti, ADC, Algernon, Biogen, Celularity, Compass, Cortexyme, Cyclerion, Cytoimmune, Denovo, Editas, Ensysce, Ideaya, In8bio, Ionis, Medicenna, Merakris, Moleculin, Mustang, Newamsterdam, Sound, Sutro, Tallac, Valbiotis, Viiv.


Read More

In the clinic for July 28, 2022

July 28, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Endonovo, QT Imaging.
Read More

In the clinic for July 27, 2022

July 27, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alimera, Alzheon, Ananda, Astellas, Athenex, Biomica, Biontech, Bridgebio, Brooklyn, Cincor, Clearside, Diffusion, Incarda, Janssen, Medicinova, Mycovia, Mymd, Oramed, Palisade, Pfizer, Reneo, Seagen, Sotio, Tracon.


Read More

In the clinic for July 19-25, 2022

July 26, 2022
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Canbridge, Daiichi Sankyo, I-Mab, Immvira, Innovent Biologics, Kyowa Kirin, Mei, Olipass, Seelos, Shionogi, Takeda, Vaxart, Yuyu.
Read More

In the clinic for July 26, 2022

July 26, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Hinge Health, Instylla, Nuvasive, Recor Medical.
Read More

In the clinic for July 26, 2022

July 26, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aligos, Ashvattha, Inmed, Nanoscope, Philogen, Revelation, Revive, Sling.


Read More

In the clinic for July 25, 2022

July 25, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Dice, Field Trip, I-Mab, Leo, Medicinova, Neuralis, Neuraptive, Tris, Vertex, Vistagen.


Read More

In the clinic for July 22, 2022

July 22, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arbutus, Assembly, Blue Lake, Canbridge, Celldex, Freeline, Hillevax, Immvira, Sonnet, Takeda.


Read More

In the clinic for July 21, 2022

July 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Appliedvr, Masimo, Veracyte.
Read More

In the clinic for July 21, 2022

July 21, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Adial, Algernon, Alvotech, Astrazeneca, Aytu, Cardior, Daiichi, Gensight, George, Hyloris, Immunomic, Inozyme, Ionis, Kowa, LB, Medikine, Merck & Co., Mesoblast, Protokinetix, Regulus, Sanofi, Siolta, Shionogi, Skye, Synaptogenix, Vaxart, VBL, Yuyu.


Read More
Previous 1 2 … 176 177 178 179 180 181 182 183 184 … 322 323 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • DNA, dollars illustration

    Latus Bio series A financing supports early-stage programs

    BioWorld Science

    Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing